GLOBE Model Lawsuit: BIO Joins Fight to Stop Medicare International Drug Pricing
BIO and two California biotech groups have sued to block Medicare’s GLOBE model, which ties Part B drug rebates to prices in 19 countries from 2027.
BIO and two California biotech groups have sued to block Medicare’s GLOBE model, which ties Part B drug rebates to prices in 19 countries from 2027.